BioRays, ROR1-Targeting BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA 07.08.2025 - 18:03:59 BioRay Pharmaceutical Co., Ltd China New York View original content:https://www.prnewswire.co.uk/news-releases/biorays-ror1-targeting-dual-epitope-adc-drug-br111-receives-formal-clinical-trial-approval-from-nmpa-302372179.html
